ReviewJapanese journal of radiology2026
Head and neck manifestations of IgG4-related disease: current understanding.
Review in Japanese journal of radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
IgG4-related disease (IgG4-RD) is a systemic fibroinflammatory condition characterized by elevated serum IgG4 levels and dense infiltration of IgG4-positive plasma cells with fibrosis in affected organs. Since its initial recognition, clinical awareness of IgG4-RD has expanded, and head and neck involvement has become increasingly well described. Among these, IgG4-related dacryoadenitis and sialadenitis (IgG4-DS), historically referred to as Mikulicz’s disease, represents the most common manifestation. Patients typically present with persistent, painless swelling of the major salivary and lacrimal glands, often accompanied by xerostomia, mild taste disturbance, or sinonasal involvement such as chronic rhinosinusitis and olfactory dysfunction. Unlike autoimmune pancreatitis, IgG4-DS affects men and women in nearly equal proportions and predominantly occurs in older individuals. Laboratory findings usually include elevated serum IgG4, hypergammaglobulinemia, eosinophilia, and high IgE levels, though none are entirely disease-specific. Diagnosis of IgG4-RD in the head and neck region requires integration of clinical, radiological, serological, and histopathological findings. Recent Japanese criteria incorporate both comprehensive and organ-specific diagnostic frameworks, while international classification criteria developed by ACR/EULAR aim to standardize patient cohorts for research. Imaging plays an important role: ultrasonography often reveals diffuse or nodular hypoechoic lesions in the salivary glands, whereas CT and MRI can delineate glandular swelling, sinonasal opacification, or pachymeningeal thickening. PET/CT may further identify multiorgan involvement, including emerging sites such as the tubarial glands. Differential diagnosis is crucial, as Sjögren’s disease, multicentric Castleman’s disease, sarcoidosis, ANCA-associated vasculitis, and malignant lymphoma can present with overlapping features, and increased IgG4-positive cells are occasionally observed in non-IgG4-related disorders. Despite uncertainties regarding its etiology, substantial progress has been made in understanding IgG4-DS, and awareness among head and neck specialists is essential to ensure accurate diagnosis and appropriate management.
Indexed as
Identifiers
41441946What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.